In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law Big FDA review coming this July. Here's what athletes and patients should know about BPC 157, TB 500, and the broader peptide conversation. Always speak with your physician before starting any new protocol. #bpc157 #